Can Lilly Stock Reach $1800 by 2030? Bulls See Path
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...
What Successful People Do Differently With Money
Learn the key money moves successful people make, from goal setting to conscious spending and informed investing that build lasting wealth.
12,910 articles
Wall Street Analyst: SpaceX IPO Could Spark Billions in IPOs
SpaceX's potential IPO is being framed by analysts as a possible catalyst for renewed public-market activity after ye...
Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Despite Pages Criticism, NASA Keeps Boeing Starliner Flying
NASA issued a comprehensive review of Boeing's Starliner program, yet the agency has not pulled the plug. Here’s how ...
Why This Fund Sold Million: A Stock Up 325% in a Year
A seasoned fund trimmed a big winner after a meteoric run. This article breaks down the why behind the move, the numb...
Prem Watsa Adds Million: Is UA Turnaround Worth It Now?
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
Arcutis Vertex: Which Pharmaceutical Stock Is Better in 2026
In 2026, investors face a classic showdown: a rapid-growth dermatology
QuantumScape Stock Down 63%: Is It Time to Buy for the Long Haul?
QuantumScape faces a volatile path from lab breakthroughs to mass production. This guide breaks down what the stock d...
Jaguar Health (JAGX) 2025 Outlook for Investors and Analysts
Jaguar Health faces a pivotal year as its key drug Mytesi and pipeline shape 2025 outcomes. This guide breaks down Q3...
Jeff Bezos Just Raised $12B to Power Prometheus Initiative
Jeff Bezos leads a $12 billion funding round for Prometheus, an AI-powered engineering platform designed to collapse ...
Lilly Teva: Which Pharmaceutical Stock Shines in 2026?
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status